103 related articles for article (PubMed ID: 30941974)
1. Effects of diabetes mellitus and Metformin administration on prostate cancer detection at biopsy among Chinese men: a case-control study.
Hu MB; Bai PD; Wu YS; Zhang LM; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
J BUON; 2019; 24(1):227-232. PubMed ID: 30941974
[TBL] [Abstract][Full Text] [Related]
2. Association between metformin use and risk of prostate cancer and its grade.
Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056
[TBL] [Abstract][Full Text] [Related]
3. The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia.
Dell'Atti L; Galosi AB
Int Braz J Urol; 2018; 44(1):69-74. PubMed ID: 29211393
[TBL] [Abstract][Full Text] [Related]
4. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
[TBL] [Abstract][Full Text] [Related]
5. Metformin use and risk of prostate cancer: results from the REDUCE study.
Feng T; Sun X; Howard LE; Vidal AC; Gaines AR; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
Cancer Prev Res (Phila); 2015 Nov; 8(11):1055-60. PubMed ID: 26353947
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
[TBL] [Abstract][Full Text] [Related]
7. Metformin Does Not Predict for Prostate Cancer Diagnosis, Grade, or Volume of Disease After Transperineal Template-guided Mapping Biopsy.
Merrick GS; Bennett A; Couture T; Butler WM; Galbreath RW; Adamovich E
Am J Clin Oncol; 2017 Aug; 40(4):353-357. PubMed ID: 25575041
[TBL] [Abstract][Full Text] [Related]
8. Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy.
Hong SK; Oh JJ; Byun SS; Hwang SI; Lee HJ; Choe G; Lee SE
Prostate; 2012 Jan; 72(1):51-7. PubMed ID: 21520162
[TBL] [Abstract][Full Text] [Related]
9. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.
Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K
Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412
[TBL] [Abstract][Full Text] [Related]
10. Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
Winters B; Plymate S; Zeliadt SB; Holt S; Zhang X; Hu E; Lin DW; Morrissey C; Wooldridge B; Gore JL; Porter MP; Wright JL
Prostate; 2015 Nov; 75(15):1694-703. PubMed ID: 26201966
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
Taneja SS; Morton R; Barnette G; Sieber P; Hancock ML; Steiner M
J Clin Oncol; 2013 Feb; 31(5):523-9. PubMed ID: 23295793
[TBL] [Abstract][Full Text] [Related]
12. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
13. Metformin and the incidence of prostate cancer in patients with type 2 diabetes.
Azoulay L; Dell'Aniello S; Gagnon B; Pollak M; Suissa S
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):337-44. PubMed ID: 21148757
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
15. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
[TBL] [Abstract][Full Text] [Related]
16. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy.
Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS
Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Proliferative Inflammatory Atrophy in Negative Prostatic Biopsies.
Servian P; Celma A; Planas J; Placer J; de Torres IM; Morote J
Prostate; 2016 Dec; 76(16):1501-1506. PubMed ID: 27404228
[TBL] [Abstract][Full Text] [Related]
19. Association between metformin medication, genetic variation and prostate cancer risk.
Lee MJ; Jayalath VH; Xu W; Lu L; Freedland SJ; Fleshner NE; Kulkarni GS; Finelli A; van der Kwast TH; Hamilton RJ
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):96-105. PubMed ID: 32424261
[TBL] [Abstract][Full Text] [Related]
20. Association of diabetes mellitus with prostate cancer grade and prostate-specific antigen in Chinese biopsy population.
Chen M; Luo Y; Yang S; Xu L; Li N; Li H; Qu S
Diabetes Res Clin Pract; 2018 Jul; 141():80-87. PubMed ID: 29684617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
